OMX30 1 532 -0,5%  OMXH25 3 872 -0,9%  OMXC20 997 -0,6%  Dow 21 675 -0,4%  Nas 5 791 -0,1%  EUR 9,5375 -0,1%  USD 8,1132 0,1%  Olja 52,8 -0,1%  Guld 1 281 -0,2% 

Baxter International Aktie

60,87USD 0,01USD 0,02%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Baxter International Chart - 1 År - BTT

Fundamentala nyckeltal för Baxter International

2016 2017e 2018e 2019e 2020e
Utdelning 0,50 0,60 0,70 0,81 0,80
Direktavkastning (i %) 1,15 1,28 1,50 1,74 1,71
PE-tal 22,22 19,55 17,53 15,49 13,80
Resultat/aktie 1,96 2,39 2,67 3,02 3,39

Nyheter om Baxter International Inc.

ytterligare nyheter

Analyser om Baxter International Inc.

ytterligare analyser

Baxter International Peer Group

Baxter International 60,87
0,0%
Boston Scientific 26,88
0,9%
Cardinal Health 64,38
-1,2%
Covidien 0,00
0,0%
Fresenius Medical Care 79,06
-1,1%
Fresenius 68,70
-1,4%
Hospira 0,00
0,0%
Medtronic 83,43
-0,3%
STRATEC Biomedical 50,43
-1,2%
pagehit

Lägg till instrument

Vad tycker du?

Profil Baxter International Inc.till bolagsprofilen

Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; premixed and oncolytic injectables; biosurgery products and anesthetics; drug reconstitution systems; and pharmacy automation, software and services. The company products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctor's offices and by patients at home under physician supervision. It operates through the following segments: Hospital Products and Renal. The Hospital Products segment intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation. The Renal segment provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis, home HD, continuous renal replacement therapy and additional dialysis services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Realtidskurs Baxter International Inc.

Bid 60,63 USD Ask 60,88 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Baxter International Inc. i USDPUSH CHART

Kurs 60,87 USD 0,01 0,02 %
Kurstid 21:59:54
Datum 18.08.2017
Öppning 60,73
Gårdagen 60,86
Dagshögsta 61,24
Dagslägsta 60,66
52 v. högsta 63,10
52 v. lägsta 43,14
52 v. perf.
Volym (Antal) 154 224
Börsvärde (SEK) 265,07 Mrd
Börsen
Kurs för 60,87 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 493,85 SEK.

Till aktien Baxter International

Ticker
ISIN US0718131099
Index S&P 100, NYSE US 100, BX Swiss - USA, S&P 500

Baxter International Nyckeltal

Börsvärde i SEK 265,07 Mrd
Free float % 99,85
Antal aktier mio. 541,96
Cashflow/aktie i lokal valuta 2,28
Bokvärde/aktie i lokal valuta 17,02
60 dagar vola 22,28
PBV 2,56

Baxter International Historiska kurser

2017-08-18 60,87 154 224
2017-08-17 60,86 157 471
2017-08-16 61,38 195 740
2017-08-15 60,77 137 273
2017-08-14 60,20 128 559